Format

Send to

Choose Destination
Trends Endocrinol Metab. 2005 Dec;16(10):478-88. Epub 2005 Nov 4.

Transcriptional corepression by SHP: molecular mechanisms and physiological consequences.

Author information

1
Department of Biosciences at Novum, Karolinska Institutet, S-14157 Huddinge, Sweden.

Abstract

Small heterodimer partner (SHP; NR0B2), an exceptional member of the mammalian nuclear receptor family, directly modulates the activities of conventional nuclear receptors by acting as an inducible and tissue-specific corepressor. Recent progress in dissecting underlying molecular mechanisms, identifying target factors and target genes, and uncovering physiological functions points to the regulatory involvement of SHP in diverse metabolic and intracellular pathways that awaits future clarification. In this review, we carry out a comprehensive survey of all published data and discuss our current understanding of molecular mechanisms and physiological consequences governing SHP action.

PMID:
16275121
DOI:
10.1016/j.tem.2005.10.005
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center